Larvol Delta - A-Study-to-Evaluate-the-Efficacy-and-Safety-of-Intravesical-Instillation-of-Disitamab-Vedotin-Combined-With-Toripalimab-in-Patients-With-HER2Positive-HighRisk-NonMuscle-Invasive-Bladder-Cancer-Who-Are-BCGNave-or-Have-BCG-Failure

Aidixi (disitamab vedotin) - Pfizer, RemeGen

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT07783815

Aug 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next